Literature DB >> 6616450

Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells.

K Nooter, G van den Engh, P Sonneveld.   

Abstract

Flow cytometry was used to determine the daunomycin content of rat bone marrow cells after incubation in vitro. The spontaneous fluorescence of daunomycin was measured upon excitation with laser light at 488 nm. Forward and perpendicular light scatters of the cells were simultaneously measured to allow identification of granulocytic and lymphocytic subpopulations. A linear relationship was found for a 30-min exposure between the drug concentration (ranging from 0.2 to 3 micrograms/ml) in the incubation medium and the fluorescence intensity for both lymphocytes and granulocytes. Dead cells contaminating cell suspensions showed several times higher daunomycin fluorescence than did viable cells. In fixed cells, the fluorescence reflects daunomycin bound to DNA, since the fluorescence intensity of daunomycin-treated fixed cells returns to the level of unstained cells after DNase treatment. Quantitation of the cellular drug concentration was done by exposing cells in vitro to varying doses of [3H]daunomycin. At each drug concentration, the fluorescence intensity of the cells was measured using flow cytometry. Granulocytes and lymphocytes were sorted on the basis of light scatter. The amount of intracellular drug was determined for both cell populations at each drug dose by measuring the radioactivity in 600,000 sorted cells. The concentration per cell was on the order of 10(-18) mol. For both the granulocytic and the lymphocytic subpopulations, a linear relationship was found between drug-related radioactivity and fluorescence intensity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616450

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Phenotypic variations dictate the intracellular compartmentalization of doxorubicin in normal human bone marrow cells.

Authors:  E Aghaï; Z A Tökés
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Multidrug resistance (MDR) genes in haematological malignancies.

Authors:  K Nooter; P Sonneveld
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.

Authors:  K Nooter; R Oostrum; R Jonker; H van Dekken; W Stokdijk; G van den Engh
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

Authors:  J Verweij; H Herweijer; R Oosterom; M E van der Burg; A S Planting; C Seynaeve; G Stoter; K Nooter
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

5.  Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line.

Authors:  K Nooter; A W Boersma; R G Oostrum; H Burger; A G Jochemsen; G Stoter
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

6.  Multidrug resistance in rat colon carcinoma cell lines CC531, CC531mdr+ and CC531rev.

Authors:  E Gheuens; S van der Heyden; H Elst; A Eggermont; A Van Oosterom; E De Bruijn
Journal:  Jpn J Cancer Res       Date:  1993-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.